IUA Committee Research Project on the Management of TASC C and D Aortoiliac Lesions

NCT06260475 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-02-15

No results posted yet for this study

Summary

This study aims to evaluate the clinical, imaging results of endovascular revascularization of the aorto-iliac sector in comparison with aortobifemoral bypass and the hybrid approach, in patients with atherosclerotic disease of the iliac sector classified as type C and D by the TransAtlantic Inter-Society Consensus (TASC II

Conditions

  • Aortoiliac Atherosclerosis
  • Aortoiliac Occlusive Disease
  • Aortoiliac Atherosclerosis With Gangrene
  • Aortoiliac Atherosclerosis Without Gangrene
  • Aortoiliac Obstruction
  • Peripheral Arterial Disease
  • Peripheral Vascular Diseases

Interventions

PROCEDURE

Aortobifemoral bypass

Open surgery with aortic and iliac reconstruction

PROCEDURE

aortoiliac stenting

Endovascular reconstruction of aortic and iliac arterial obstruction: Balloon angioplasty may be performed initially to dilate the narrowed segment of the iliac artery. Subsequently, a stent delivery system is advanced over the wire and positioned across the lesion. The stent is deployed under fluoroscopic guidance to expand and scaffold the diseased artery, restoring blood flow. Vascular - iliac dedicated Stent - any brand

Sponsors & Collaborators

  • Clinical Centre of Serbia

    collaborator OTHER
  • University of Padova

    collaborator OTHER
  • University of Bari

    collaborator OTHER
  • University of Trieste

    collaborator OTHER
  • University of Nis

    collaborator OTHER
  • Centro Hospitalar de Vila Nova de Gaia/Espinho

    collaborator OTHER
  • Hospital Centre Hospitalar de Trás-os-Montes e Alto Douro

    collaborator OTHER
  • Centro Hospitalar do Porto

    collaborator OTHER
  • Universidade do Porto

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-08-31
Completion
2024-12-31
FDA Device
Yes

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06260475 on ClinicalTrials.gov